Heartflow (NASDAQ:HTFL) Now Covered by Analysts at Morgan Stanley

Morgan Stanley assumed coverage on shares of Heartflow (NASDAQ:HTFL) in a research report released on Tuesday morning, Marketbeat Ratings reports. The firm issued an equal weight rating and a $35.00 price objective on the stock.

A number of other equities research analysts also recently issued reports on the company. Piper Sandler initiated coverage on Heartflow in a research report on Tuesday. They set an “overweight” rating and a $38.00 price target for the company. Stifel Nicolaus initiated coverage on Heartflow in a research report on Tuesday. They set a “buy” rating and a $35.00 price target for the company. Wall Street Zen raised Heartflow to a “hold” rating in a research report on Saturday, August 16th. Canaccord Genuity Group initiated coverage on Heartflow in a research report on Tuesday. They set a “buy” rating and a $35.00 price target for the company. Finally, JPMorgan Chase & Co. initiated coverage on Heartflow in a research report on Tuesday. They set an “overweight” rating and a $36.00 price target for the company. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Heartflow has an average rating of “Moderate Buy” and a consensus price target of $35.80.

Heartflow Stock Performance

HTFL stock opened at $31.16 on Tuesday. Heartflow has a 52-week low of $26.56 and a 52-week high of $36.68.

Heartflow Company Profile

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.